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Quantum Chemical Calculations and Mutational
Analysis Suggest Heat Shock Protein 90
Catalyzes Trans-Cis Isomerization of Geldanamycin
molecules is important for rational design of novel
HSP90 inhibitors, and the binding process, particularly
in the case of GA, is not as simple as it may appear.
For example, although the affinity of GA for purified
HSP90 is approximately 1 M in vitro [6], its apparent
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Building 12A, Room 2049 affinity in a cell extract is in the low nanomolar range
Bethesda, Maryland 20892 [10, 11]. This is in distinct contrast to radicicol, which
2 Urologic Oncology Branch has a similar low nanomolar affinity for HSP90 both in
Center for Cancer Research its purified form and in a cellular milieu [6, 12]. Further-
National Cancer Institute more, a synthetic molecule based on a purine scaffold
Rockville, Maryland 20850 binds with micromolar affinity to both purified and cellu-
lar HSP90 [9].
Although the X-ray structure shows that the conforma-
tion of radicicol bound to the ATP/ADP binding site of
HSP90 is identical to that of unbound radicicol [6], theSummary
conformation of GA bound to HSP90 is significantly dif-
ferent from that of unbound GA. GA bound to HSP90The affinity of geldanamycin (GA) for binding to heat
adopts a compact conformation in which the benzoqui-shock protein 90 (HSP90) is 50- to 100-fold weaker
none and ansa rings are parallel to each other and re-than is the affinity of the structurally distinct natural
semble a C-clamp-like structure, whereas unbound GAproduct radicicol. X-ray crystallography shows that
preferentially adopts an extended conformation [7, 8].although radicicol maintains its free conformation
The difference in conformation between bound and un-when bound to HSP90, the conformation of GA is dra-
bound GA has been attributed to the loss of coplanaritymatically altered from an extended conformation with
between the amide group and the benzoquinone in thea trans amide bond to a kinked shape in which the
compact conformation as well as to differences in sol-amide group in the ansa ring has the cis configuration.
vents used during crystallization.We have performed ab initio quantum chemical calcu-
Examination of the X-ray structure of bound GA indi-lations to demonstrate that the trans-cis isomeriztion
of GA in solution is both kinetically and thermodynami- cates that the amide group bonded to the benzoquinone
cally unfavorable. Thus, we propose that HSP90 cata- has a cis (Figure 1C) configuration. This is in direct con-
lyzes the isomerization of GA. We identify Ser113, a trast with the X-ray structures of unbound ansamycins
conserved residue outside the ATP binding pocket, as such as GA [13], herbimycin [14], and macbecin [15],
essential for the isomerization of GA. In support of this which all show the same amide group in a trans configu-
model, we show that radicicol binds equally well to ration. The fact that the dihedral angle, C20-N22-C1-O,
both wild-type HSP90 and the Ser113 mutant, whereas of bound GA (165) is significantly different from that
the binding of GA to the Ser113 mutant is decreased of unbound GA (8), herbimycin (9), or macbecin (8)
significantly from its binding to wild-type HSP90. further supports that GA bound to HSP90 exists in the
Based on this finding, a mechanism of keto-enol tauto- cis configuration.
merization of GA catalyzed by HSP90 is proposed. Based on targeted molecular-dynamics simulations
The added requirement of isomerization prior to tight (TMD) of a GA derivative, 17-desmethoxy-17-N-N-dimeth-
binding may explain the enhanced binding affinity of ylaminoethylaminogeldanamycin (17-DMAG), Jez et al.
GA for HSP90 in a cell extract versus in a purified form. have recently pointed out that 17-DMAG needs to un-
dergo both macrocyclic ring conformational change and
trans-cis isomerization of the amide in order to bind toIntroduction
HSP90 [16]. By assuming that the bound 17-DMAG has
Radicicol (Figure 1A) and geldanamycin (GA, Figure 1B) the cis amide configuration, this work studied the struc-
are structurally distinct antibiotics that specifically bind tural change of 17-DMAG by using molecular-mechan-
to an amino-terminal nucleotide pocket in the molecular ics force-field analysis to transform the trans amide to
chaperone heat shock protein 90 (HSP90) [1–4]. Drug the cis form. This TMD study has provided insight into
binding inhibits the chaperone’s ability to stabilize a the process of trans-cis isomerization of 17-DMAG
host of client proteins, many of which cancer cells use to within the scope of a molecular-mechanics approxima-
promote their survival in toxic environments [5]. Recent tion. Although rotation of the C-N bond faces a substan-
X-ray crystallographic structures of HSP90 complexed tial energy barrier of approximately 20 kcal/mol [17, 18],
with either radicicol [6] or GA [7, 8] have spurred great as well as a rearrangement of  electrons, the TMD
interest in designing inhibitors of HSP90 with enhanced study has not considered the energy barrier for the isom-
potency and specificity [9]. erization of the amide bond. Therefore, this process
Understanding the binding mechanics of these small needs to be examined at a higher level of quantum
chemistry, i.e., the approach needs to go beyond molec-
ular mechanics. In addition, the TMD study has assumed*Correspondence: leeys@mail.nih.gov
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Figure 1. Chemical structures of radicicol
and GA
(A) Radicicol.
(B) Trans-GA.
(C) Cis-GA.
that trans-cis isomerization of 17-DMAG occurs sponta- thermodynamic calculation reported here that equilib-
rium in solvent greatly favors trans-GA (Keq  1011).neously without participation of HSP90.
In the present work, we have carried out ab-initio
quantum chemical calculations on both free and bound Trans-cis Isomerization of GA
GA to compare their geometry and energetics. We also Rigid docking studies of GA to HSP90 indicate that ex-
constructed the reaction path of the trans-cis isomeriza- tended trans-GA cannot be fitted into the active site. To
tion of GA by rotating the C20-N22 and C1-N22 bond adopt the conformation of bound cis-GA, the extended
of GA (Figure 1C). We then combined these calculations trans-GA in solution must undergo flipping of the ansa
with the study of site-directed mutagenesis of HSP90 ring over the benzoquinone as well as trans-cis isomer-
to identify the amino acid residue likely to be involved ization of the amide bond. The flipping of the ansa ring
in the isomerization of GA. Based on these findings, a can occur readily as evidenced by the X-ray structures
mechanism for the trans-cis isomerization of GA as well of ansamycins, which have shown that the ansa ring
as a rationale for the enhanced binding affinity of GA can be positioned on either side of the benzoquinone.
for HSP90 in a cell extract is given. However, the trans-cis isomerization involves a breaking
of the C-N amide bond, which requires a substantial
energy because of its partial double-bond character.Results and Discussion
The question is then whether this trans-cis isomerization
occurs spontaneously or is assisted by residues ofGeometry and Energetics
HSP90. The spontaneous process in solution can beThe geometry-optimized structures of extended trans-
ruled out because the conversion of trans to cis GA isGA and compact cis-GA are illustrated in Figures 2A
thermodynamically unfavorable by 15.5 kcal/mol (Tableand 2B, respectively. The optimized conformations of
1) irrespective of the rotational energy barrier of the C-Nboth closely resemble their respective starting X-ray
bond. Therefore, we hypothesize that HSP90 lowers thestructures. For example, the superposition of heavy
energy barrier for the isomerization of GA, and the re-atoms of the optimized cis-GA onto bound GA gives a
sulting cis-GA is subsequently stabilized by interactionroot mean square deviation of 0.51 A˚. Both optimized
with the residues of HSP90 as observed in the X-raystructures have a longer C1-N22 amide bond distance
structures. To explore this hypothesis, we individually(1.39 A˚ for trans and 1.41 A˚ for cis) coupled with a shorter
mutated Lys112 and Ser113 residues of HSP90 to ala-C20-N22 distance (1.37 A˚ for trans and 1.39 A˚ for cis).
nine and examined the ability of the resultant point mu-These bond distances indicate that the lone pair of elec-
tants to bind to immobilized GA and to immobilizedtrons on the amide nitrogen is delocalized over the C20
ATP. These particular residues were chosen based onatom of the quinone and the C1 atom of the amide
docking of the optimized extended trans-GA outside thegroup.
binding pocket of GA. As illustrated in Figure 3, the sideTable 1 lists the energetics of GA at 298.5 K in the
chain of both Lys112 and Ser113 of HSP90 can H-bondgaseous phase. These values are essentially identical
with the amide oxygen of trans-GA, and this may facili-to those values calculated in DMSO, suggesting that
tate the trans-cis isomerization process. Ser113 is ansolvent effects are negligible. The extended trans-GA
ideal candidate for this role not only because of its strictconformation in DMSO is 13.8 kcal/mol more stable than
conservation among HSP90 family members but alsothe cis-GA in a compact conformation. When the entropy
because it is located where the putative isomerizationcontribution is included, the free-energy difference
would have to occur, outside of the nucleotide bindingbetween the two isomers increases to 15.5 kcal/mol
pocket.because the cis-GA in a compact conformation has a
slightly lower entropy than the extended trans-GA.
These energetics clearly demonstrate that virtually all Mutational Analysis of HSP90 Binding
to Immobilized GA and ATPGA (99.9999999%) exists in an extended trans configu-
ration, explaining why the reported X-ray structures of As shown in Figure 4A (left panel), binding of GA to the
S113A HSP90 point mutant was markedly impaired. GAunbound ansamycins have depicted only the trans con-
figuration. In addition, preliminary NMR analysis has binding to the K112A mutant was also reduced in com-
parison to wild-type HSP90. The published X-ray struc-shown only a single broad resonance for the amide
hydrogen of GA at milimolar concentration in DMSO ture of GA bound to HSP90 shows that Lys112 forms
an H-bond with the quinone oxygen of GA (Figure 3) at(Barchi et al., unpublished data). Previous NMR evalua-
tion of GA in CDCl3 has also reported only a single spe- the solvent-exposed entrance to the nucleotide binding
pocket [7]. The K112A mutant may display partially im-cies [19]. These NMR findings are consistent with the
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Figure 2. Ab Initio Energy-Minimized Struc-
tures of GA
(A) Extended trans-GA.
(B) Compact cis-GA. Atoms represented by
colors: white, carbon; green, hydrogen; blue,
nitrogen; and red, oxygen.
paired GA binding as a result of the loss of this ing wild-type HSP90. These data indicate strongly that
S113 is involved in the initial binding of trans-GA toH-bonding interaction. However, the X-ray structure
does not provide an obvious structural basis for the HSP90 prior to its isomerization. Although it is possible
that a conformational change in the S113A mutant pre-dramatic impairment of GA binding by the S113A mu-
tant. In fact, the X-ray structure shows that Ser113 is vents GA from entering the pocket, it is difficult to recon-
cile this speculation with the fact that the binding of thenot positioned to interact directly or indirectly with either
GA or radicicol. more structurally rigid radicicol is not affected by this
mutation. Based on a recent study [20] that used compu-Figure 4B demonstrates that although GA has diffi-
culty displacing the S113A mutant from ATP beads, radi- tational modeling to link the individual X-ray structures
of the N-terminal and middle domains of HSP90, it couldcicol is as effective in this regard as it is toward displac-
be argued that GA would not have access to S113 in
the context of the complete protein. This model was
based on the assumption that the conformation ofTable 1. Relative Energetics of Geldanamycin (kcal/mol) at
298.5 K HSP90 can be inferred by homology from crystallo-
graphic data obtained from Gyrase B and Mutl, twoB3LYP/6-31G*
other ATP binding proteins that share similar nucleotideEnthalpy Gibbs Free energy
binding site topology with HSP90. However, this as-
extended trans-GA 0 0
sumption is highly speculative because neither GA norcompact cis-GA 13.3 (13.8)a 14.9(15.5)a
radicicol bind to either Gyrase B or Mutl proteins (Neck-
aSingle point energy calculation in DMSO with the Onsager method ers et al., unpublished observations). Thus, the homol-
[29]
ogy between these three proteins is clearly not sufficient
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Figure 3. Proposed Binding Site of trans-GA
Bound GA (1a4h) H-bonded to Asp93 and
Lys112 is shown in yellow. The red box indi-
cates the cis-amide group of the bound GA;
the green box indicates the carbamate group
of both trans and bound GA. The optimized
trans-GA was docked to H-bond with Lys112
and Ser113; the Ser113 oxygen was steered
to H-bond with the amide oxygen. Trans-GA
is likely to undergo trans-cis isomerization
with the assistance of Lys112 and Ser113
which, in turn, results in a flipping of the ansa
ring. The green arrow indicates, schemati-
cally, a possible pathway through which GA
could enter the binding pocket after the isom-
erization.
to allow one to correctly predict whether the proposed
trans-GA binding site in the N-terminal domain of HSP90
is sterically hindered in the complete protein. Further-
more, it is very unlikely that the proposed trans-GA bind-
ing site overlaps with the middle segment of HSP90
because it is adjacent to the ATP binding pocket as
shown in Figure 3.
Proposed Mechanism for trans-cis
isomerization of GA
To investigate the putative trans-cis isomerization pro-
cess, we rotated the C1-N22 amide bond of the trans-
GA by varying the dihedral angle of H-N22-C1-O
from 170 to 0 in increments of 10 while relaxing
the rest of structure. The calculated energy barrier to
rotation about this amide bond is 12.4 kcal/mol. Al-
though the extended GA at the dihedral angle of 0 has
the cis configuration (Figure 5), the amide hydrogen has
an orientation that is almost opposite to that of the
compact cis-GA (Figure 2B). This suggests that the C20-
N22 bond of the trans-GA also needs to be rotated in
Figure 4. Binding Characteristics of Wild-Type and Point-Mutated order for the molecule to adopt the conformation of
HSP90 to GA and ATP
bound GA. Figure 6 illustrates that the potential energy
(A) Binding of wild-type and mutated HSP90 to immobilized GA and of GA goes up as the dihedral angle of H-N22-C20-C21
ATP resins. [35S]methionine-labeled wild-type HSP90 and the K112A
increases from 0 to 90. After passing the transitionand S113A mutants were prepared by in vitro translation and tested
for binding to either GA resin or ATP resin, as described in the
Experimental Procedures. The amount of HSP90 added to the beads
was normalized based on efficiency of translation. Bound HSP90
was eluted from the beads by being boiled in denaturing-gel loading
buffer, and samples were separated by polyacrylamide gel electro-
phoresis. Gels were dried and exposed to X-ray film for 1–2 days.
(B) Displacement of wild-type and S113A HSP90 from ATP-Sepha-
rose beads. Radiolabeled HSP90 was prepared as above and incu-
bated with ATP-Sepharose beads. In this experiment, three times
as much S113A-containing lysate (compared to wild-type HSP90-
containing lysate) was used, and film was exposed for 7 days in order
to detect S113A binding to ATP beads. Increasing concentrations (0,
10, 100 nM) of GA and radicicol (RD) were added to the translated
HSP90 30 min prior to addition of ATP beads, and samples were Figure 5. Schematic Representation of the Extended cis-GA. R and
R indicate the portion of the ansa ring of GArotated at 4C. Bound HSP90 was eluted and processed as above.
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Figure 6. Plot of the Potential Energy of
trans-GA versus the Dihedral Angle of H-N22-
C20-C21
state, the potential energy remains rather flat until the An alternative, more plausible rationale is that the
isomerization of GA occurs through keto-enol tautomeri-dihedral angle reaches 170. The calculated rotational
energy barrier of the C20-N22 bond is 13.7 kcal/mol, zation assisted by Lys112 and Ser113 as depicted in
Figure 7. Because the amide hydrogen, like the iminewhich is 1.3 kcal/mol higher than that of the C1-N22
amide bond and is in good agreement with the fact that hydrogen of the hydantoin ring, is very acidic, GA can
exist as keto-enol tautomers. A and D depict trans- andthe C20-N22 bond distance is 0.02 A˚ shorter than the
C1-N22 bond. This strongly suggests that the rotation cis-GA, respectively. Upon deprotonation of the amide
hydrogen of A, an enol (B) can be formed by abstractionof the C20-N22 bond is a rate-determining step for the
isomerization of GA, thus making the trans-cis isomer- of a proton from Lys112. As a consequence, the C20-
N22 bond of B can rotate readily. C is another enolization of the amide bond of secondary importance.
Due to extensive computational requirements, the formed by the proton transfer from the protonated
Lys112 to the quinone oxygen atom. This enolizationoverall energy barrier for trans-cis isomerization of GA
was not calculated. Nonetheless, judging from the ther- makes the amide C1-N22 bond of C also rotatable. As
a consequence of the rotation of both C20-N22 and C1-modynamic stability of trans-GA (15.5 kcal/mol) as com-
pared to cis-GA and the sizable rotational energy barrier N22 bonds, the cis-GA (D) results when the nitrogen
atom of C is reprotonated. The reported H-bond be-of the C20-N22 and C1-N22 bonds, the overall energy
barrier for the isomerization of GA is expected to be tween the quinone oxygen of GA and Lys112 (Figure 3)
is likely to arise from this keto-enol tautomerization, inwell in excess of 20 kcal/mol, making the process also
kinetically unfavorable. Unlike in solution, the thermody- which Lys112 promotes the tautomerization by provid-
ing a proton to shuttle between the quinone and amidenamic instability of the compact cis-GA could be over-
come by interaction energies provided by residues of oxygen atoms while Ser113 binds to the amide oxygen
of GA for initial docking and then assists the directionHSP90 in the ATP binding pocket. However, in order for
GA to interact with HSP90, both the C20-N22 and C1- of rotation from trans to cis. In the absence of Lys112,
the proton shuttling is likely to be carried out by a proton-N22 bonds of trans-GA must first be rotated.
Although it is not clear a priori how HSP90 lowers the ated water molecule. This may explain how the K112A
mutant can still bind GA, albeit with reduced efficiency.rotational energy barriers, one possibility is that Ser113
plays mainly a structural role in docking the trans-GA Interestingly, we found that, when compared to the
K112A mutant or to wild-type HSP90 (Figure 4A, rightnear to the binding pocket. After docking, the rotation
of both C20-N22 and C1-N22 bonds as well as the flip- panel), the S113A mutant bound poorly to ATP resin.
ATP may exist in a number of orientations, but only oneping of the ansa ring over the benzoquinone may some-
how transform the trans-GA to the compact cis-GA, for is likely to enter the pocket. Superposition of ADP to
GA [6] shows that the amide group of GA and theexample by an induced fit. The resulting conformation
change would allow Asp93 at the bottom of the ATP -phosphate group of ADP overlap well, as evidenced
by the fact that the P atom of the phosphate and thebinding pocket to steer the carbamate group of cis-GA
into the binding pocket, presumably via electrostatic C1 atom of the amide group are only separated by 0.4 A˚.
This suggests that Lys112 and Ser113 may also H-bondinteraction (Figure 3). However, an induced fit by HSP90
alone is highly unlikely to provide sufficient energy to with the -phosphate group of ATP. By this H-bonding
interaction, Ser113 may act as a gatekeeper by permit-overcome the rotational barrier for the C20-N22 and C1-
N22 bonds, which have a partial double bond character, ting only a particular conformer of ATP to enter the
HSP90 binding pocket.and this makes the uncatalyzed conversion of trans-GA
to cis-GA untenable, even in the vicinity of the ATP Because of its thermodynamic instability, it should
only be possible to detect cis-GA when it is bound tobinding pocket of HSP90.
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Figure 7. Schematic Representation of the
GA trans-cis Isomerization Catalyzed by
Lys112 and Ser113 of HSP90
A and D depict trans- and cis-GA, respec-
tively. Upon deprotonation of the amide hy-
drogen of A, an enol (B) can be formed by
abstraction of a proton from Lys112. As a
consequence, the C20-N22 bond of B can be
rotated readily. C is another enol form that
allows the rotation of the C20-N22 bond. The
cis-GA (D) results when the nitrogen atom of
C is reprotonated upon the rotation of the C1-
N22 bond and the flipping of the ansa ring.
In this scheme, Lys112 promotes a keto-enol
tautomerization by providing a proton to shuttle
between the quinone and amide oxygen atoms,
whereas Ser113 binds to the amide oxygen of
GA for initial docking and then assists the
direction of rotation from trans to cis.
HSP90. The vibrational frequency calculations suggest contrast to radicicol, whose HSP90 binding affinity is
uniformly in the low nanomolar range, the binding affinitythat the bending modes of N-H of trans- and cis-GA are
significantly different both in frequency and intensity of GA for purified HSP90 is approximately 1M, whereas
in a cell extract its affinity is increased 50- to 100-fold.(details will be published elsewhere). Thus using these
bending frequencies as a marker, one can use FT-IR In cells, HSP90 is associated with a number of cochaper-
one proteins that modify its activity [26]. Indeed, a recentdifferential spectroscopy to investigate the process of
GA trans-cis isomerization mediated by HSP90. This will study has demonstrated that the affinity of purified
HSP90 for GA is dramatically improved upon additionyield a spectroscopic identification of cis-GA aside from
the X-ray structures. of purified cochaperone proteins to the binding assay
[27]. The possibility exists that one or more associatedHSP90 recognizes misfolded proteins and partici-
pates in their refolding in concert with other molecular cochaperones further facilitates HSP90-dependent
isomerization of trans-GA to cis-GA, perhaps by provid-chaperones [21]. These misfolded proteins may contain
some cis peptide bonds. Whether the HSP90-dependent ing a basic residue to abstract the amide hydrogen and
thereby enhancing apparent affinity. Another possibilityisomerization of GA is catalyzed by a motif in the chaper-
one that helps rectify misfolded proteins via cis-trans is that one or more of these cochaperones might help
trap cis-GA so that it can be drawn into the ATP bindingisomerization of their peptide bonds remains to be seen.
Nonetheless, this possibility finds support in a recent pocket more readily. Because radicicol requires no
isomerization to bind to HSP90, its affinity does notNMR study demonstrating cis-trans isomerization of
non-prolyl-containing peptides by HSP70 [22]. Does depend on the presence of cochaperones or other cellu-
lar factors.HSP90 view GA as a misfolded protein? Intriguingly, one
of the original cocrystallization studies documenting GA
binding to HSP90 speculated that the drug was recog- Significance
nized by the chaperone as a peptide mimetic [7]. Al-
though this interpretation of the function of the GA bind- Quantum chemical calculations have demonstrated
that free GA exists in a trans configuration in solution.ing pocket was eventually proven to be incorrect, Ser113
is not in the nucleotide pocket, and its involvement in Because trans-to-cis isomerization is thermodynami-
cally unfavorable by 15.5 kcal/mol, it is highly likelyan uncharacterized but spatially related peptide binding
domain remains a possibility. Indeed, an N-terminal pep- that HSP90 itself catalyzes the process. Based on the
loss of GA binding to a Ser113 point mutant, it appearstide binding site in HSP90 and its endoplasmic reticu-
lum-localized homolog GRP94 has been described [23– that the Ser113 residue of HSP90 is essential for pro-
moting isomerization of trans-GA to cis-GA. We pro-25]. Furthermore, GA and ATP have been shown to
decrease the peptide binding affinity of the N-terminal pose that HSP90 catalyzes the isomerization of GA
through keto-enol tautomerization assisted by Lys112site while stimulating the release of already associated
peptide [23, 24]. In contrast, both radicicol and peptide and Ser113. The enhanced affinity of HSP90 for GA
upon addition of purified cochaperone proteins maycan bind simultaneously to the N-terminal domain of
GRP94 [25]. arise from further facilitation of HSP90-dependent
isomerization of trans-GA to cis-GA by one or moreThese data may also help explain the fact that, in
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